title: Effects of preventive, early, and late antifungal chemotherapy with fluconazole in different granulocytopenic models of experimental disseminated candidiasis.
abstract: To investigate the potential use of fluconazole for prevention and treatment of disseminated candidiasis in granulocytopenic patients, its in vivo antifungal activity was studied in three models of disseminated candidiasis in persistently granulocytopenic rabbits: acute, subacute, and chronic disseminated candidiasis. Fluconazole was compared with the combination of amphotericin B and flucytosine for preventive, early, and late treatment of disseminated candidiasis, depending on the model. Fluconazole was most effective when used for preventive or early treatment of acute and subacute disseminated candidiasis. When compared with the combination of amphotericin B plus flucytosine, fluconazole was similarly effective in early treatment of acute and subacute disseminated candidiasis. When treatment was delayed 6 days after established infection, fluconazole was less active in clearing tissues in comparison with its activity in preventive and early treatment. The combination of amphotericin B plus flucytosine, however, was significantly more active than fluconazole in treatment of chronic disseminated candidiasis in all tissues. In summary, fluconazole was most effective against disseminated candidiasis in persistently granulocytopenic rabbits when used for prevention or early treatment.
authors: Pediatric Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland 20892.
authors: T J
authors: TJ
authors: Walsh
authors: S
authors: S
authors: Aoki
authors: F
authors: F
authors: Mechinaud
authors: J
authors: J
authors: Bacher
authors: J
authors: J
authors: Lee
authors: M
authors: M
authors: Rubin
authors: P A
authors: PA
authors: Pizzo
mesh_terms: D000208:Acute Disease; D000380:Agranulocytosis / Q000150:complications*; D000666:Amphotericin B / Q000627:therapeutic use; D000818:Animals; D002177:Candidiasis / Q000150:complications / Q000188:drug therapy* / Q000517:prevention & control; D002908:Chronic Disease; D004195:Disease Models, Animal; D005260:Female; D015725:Fluconazole / Q000627:therapeutic use*; D005437:Flucytosine / Q000627:therapeutic use; D007668:Kidney / Q000382:microbiology; D008099:Liver / Q000382:microbiology; D011817:Rabbits; D013047:Specific Pathogen-Free Organisms
chemical_list: D000666:Amphotericin B; D015725:Fluconazole; D005437:Flucytosine